125 related articles for article (PubMed ID: 7583019)
1. The glucocorticoid receptor synergizes with Jun homodimers to activate AP-1-regulated promoters lacking GR binding sites.
Teurich S; Angel P
Chem Senses; 1995 Apr; 20(2):251-5. PubMed ID: 7583019
[TBL] [Abstract][Full Text] [Related]
2. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
3. Phenylethanolamine N-methyltransferase gene expression: synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor.
Wong DL; Siddall BJ; Ebert SN; Bell RA; Her S
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):154-61. PubMed ID: 9795195
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor.
Wei P; Vedeckis WV
Endocrine; 1997 Dec; 7(3):303-10. PubMed ID: 9657066
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins.
Harrison RJ; McNeil GP; Dobner PR
Mol Endocrinol; 1995 Aug; 9(8):981-93. PubMed ID: 7476995
[TBL] [Abstract][Full Text] [Related]
6. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter.
Wei P; Inamdar N; Vedeckis WV
Mol Endocrinol; 1998 Sep; 12(9):1322-33. PubMed ID: 9731701
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription.
Maroder M; Farina AR; Vacca A; Felli MP; Meco D; Screpanti I; Frati L; Gulino A
Mol Endocrinol; 1993 Apr; 7(4):570-84. PubMed ID: 8388998
[TBL] [Abstract][Full Text] [Related]
9. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene.
Malkoski SP; Dorin RI
Mol Endocrinol; 1999 Oct; 13(10):1629-44. PubMed ID: 10517666
[TBL] [Abstract][Full Text] [Related]
10. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites.
Pearce D; Matsui W; Miner JN; Yamamoto KR
J Biol Chem; 1998 Nov; 273(46):30081-5. PubMed ID: 9804760
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor.
Göttlicher M; Heck S; Doucas V; Wade E; Kullmann M; Cato AC; Evans RM; Herrlich P
Steroids; 1996 Apr; 61(4):257-62. PubMed ID: 8733011
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
Vial E; Perez S; Castellazzi M
Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
[TBL] [Abstract][Full Text] [Related]
14. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1.
Heck S; Kullmann M; Gast A; Ponta H; Rahmsdorf HJ; Herrlich P; Cato AC
EMBO J; 1994 Sep; 13(17):4087-95. PubMed ID: 8076604
[TBL] [Abstract][Full Text] [Related]
15. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization.
Zhou XF; Shen XQ; Shemshedini L
Mol Endocrinol; 1999 Feb; 13(2):276-85. PubMed ID: 9973257
[TBL] [Abstract][Full Text] [Related]
16. Influence of the glucocorticoid receptor on c-fos inducibility in activated ras-containing mouse lung cells.
Johnson TA; Li J; Beer DG
Mol Carcinog; 1996 Oct; 17(2):70-7. PubMed ID: 8890955
[TBL] [Abstract][Full Text] [Related]
17. Differential and antagonistic effects of v-Jun and c-Jun.
Gao M; Morgan I; Vogt PK
Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
[TBL] [Abstract][Full Text] [Related]
18. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
Butticè G; Duterque-Coquillaud M; Basuyaux JP; Carrère S; Kurkinen M; Stéhelin D
Oncogene; 1996 Dec; 13(11):2297-306. PubMed ID: 8957070
[TBL] [Abstract][Full Text] [Related]
19. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
